Protecting Our Future
ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100 existing variants of S. pneumoniae, or pneumococcal, bacteria.
Pioneering vaccines to prevent the world’s most serious infections.
We are building a future where universal, broadly protective bacterial vaccines prevent the most serious infectious diseases, saving lives, reducing antibiotic use, and containing antimicrobial resistance.
We continue to lead the fight against this defining healthcare challenge.
– Dr. Neil Murray. CEO
Mission
Our mission is clear: to protect lives by developing novel, broad-coverage vaccines that tackle antimicrobial resistance at its source.
